Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 698 of 1,261
  1. US 9320731

    7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

    THERON PHARMACEUTICALS, INC. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  2. US 9320796

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  3. US 9321834

    Anti-malarial compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  4. US 9321736

    Pyrimidine cyclohexyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  5. US 9320814

    Polyplexes of hydrophobically-modified siRNA for delivery of siRNA

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  6. US 9320734

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  7. US 9316646

    Anti-human ROR1 antibodies

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  8. US 9314424

    Pastes for injection of a therapeutic agent

    XERIS PHARMACEUTICALS, INC. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  9. US 9314486

    Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation

    Montefiore Medical Center · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  10. US 9314517

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  11. US 9315463

    Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

    Almirall, S.A. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  12. US 9315480

    Compositions of tolperisone

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  13. US 9315534

    Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  14. US 9315813

    Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes

    Alnylam Pharmaceuticals, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  15. US 9315826

    Nucleic acids containing a synthetic codon-optimized Sin Nombre virus full-length M gene

    The United States of America as rep. by the Sec'y of the Army, for U.S. Army Medical Research Institute of Infectious Diseases · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  16. US 9315568

    Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders

    ADHERON THERAPEUTICS, INC. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  17. US 9315495

    Antibacterial agents: aryl myxopyronin derivatives

    Provid Pharmaceuticals Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  18. US 9315467

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  19. US 9315811

    Methods for modulating kallikrein (KLKB1) expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  20. US 9314598

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  21. US 9314567

    Electro-osmotic pumps, systems, methods, and compositions

    The Board of Regents of the University of Texas System · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  22. US 9314552

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  23. US 9314532

    Drug delivery vehicle

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  24. US 9315458

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.